nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—ABCB1—esophageal cancer	0.671	1	CbGaD
Albendazole—TUBA1A—neck—esophageal cancer	0.00762	0.109	CbGeAlD
Albendazole—TUBA1A—epithelium—esophageal cancer	0.00518	0.0744	CbGeAlD
Albendazole—TUBA1A—bronchus—esophageal cancer	0.00511	0.0732	CbGeAlD
Albendazole—TUBA1A—smooth muscle tissue—esophageal cancer	0.005	0.0716	CbGeAlD
Albendazole—TUBA1A—trachea—esophageal cancer	0.00458	0.0657	CbGeAlD
Albendazole—TUBA1A—digestive system—esophageal cancer	0.00394	0.0566	CbGeAlD
Albendazole—TUBB4B—bronchus—esophageal cancer	0.0034	0.0488	CbGeAlD
Albendazole—TUBB4B—smooth muscle tissue—esophageal cancer	0.00333	0.0478	CbGeAlD
Albendazole—TUBA1A—lung—esophageal cancer	0.00329	0.0472	CbGeAlD
Albendazole—TUBB4B—trachea—esophageal cancer	0.00306	0.0438	CbGeAlD
Albendazole—TUBB4B—digestive system—esophageal cancer	0.00263	0.0377	CbGeAlD
Albendazole—TUBA1A—lymph node—esophageal cancer	0.00225	0.0323	CbGeAlD
Albendazole—TUBB4B—lung—esophageal cancer	0.0022	0.0315	CbGeAlD
Albendazole—CYP1A1—epithelium—esophageal cancer	0.00193	0.0277	CbGeAlD
Albendazole—CYP1A1—bronchus—esophageal cancer	0.00191	0.0273	CbGeAlD
Albendazole—CYP1A1—trachea—esophageal cancer	0.00171	0.0245	CbGeAlD
Albendazole—TUBB4B—lymph node—esophageal cancer	0.0015	0.0215	CbGeAlD
Albendazole—CYP1A2—digestive system—esophageal cancer	0.00149	0.0214	CbGeAlD
Albendazole—CYP1A1—digestive system—esophageal cancer	0.00147	0.0211	CbGeAlD
Albendazole—CYP1A2—lung—esophageal cancer	0.00125	0.0179	CbGeAlD
Albendazole—CYP1A1—lung—esophageal cancer	0.00123	0.0176	CbGeAlD
Albendazole—CYP3A4—digestive system—esophageal cancer	0.00108	0.0155	CbGeAlD
Albendazole—Mebendazole—ABCB1—esophageal cancer	0.00106	1	CrCbGaD
Albendazole—ABCB1—epithelium—esophageal cancer	0.001	0.0144	CbGeAlD
Albendazole—ABCB1—trachea—esophageal cancer	0.000889	0.0127	CbGeAlD
Albendazole—CYP1A1—lymph node—esophageal cancer	0.000841	0.0121	CbGeAlD
Albendazole—ABCB1—digestive system—esophageal cancer	0.000765	0.011	CbGeAlD
Albendazole—ABCB1—lung—esophageal cancer	0.000639	0.00916	CbGeAlD
Albendazole—ABCB1—lymph node—esophageal cancer	0.000437	0.00626	CbGeAlD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.00019	0.000747	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—FBXW7—esophageal cancer	0.00019	0.000747	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000189	0.000744	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000188	0.000738	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000188	0.000738	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000187	0.000734	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000186	0.000731	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000186	0.000731	CbGpPWpGaD
Albendazole—Body temperature increased—Carboplatin—esophageal cancer	0.000186	0.0414	CcSEcCtD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000176	0.000694	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000173	0.000682	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000172	0.000675	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000171	0.000673	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	0.00017	0.00067	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CDKN2A—esophageal cancer	0.000169	0.000665	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.000167	0.000657	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000167	0.000656	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—CASP8—esophageal cancer	0.000167	0.000655	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	0.000162	0.000637	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000161	0.000634	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	0.00016	0.00063	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00016	0.000629	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.00016	0.000628	CbGpPWpGaD
Albendazole—CYP1A1—PPARA activates gene expression—CREBBP—esophageal cancer	0.000159	0.000627	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000159	0.000626	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000157	0.000617	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000156	0.000615	CbGpPWpGaD
Albendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—esophageal cancer	0.000156	0.000613	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000155	0.000608	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	0.000152	0.000597	CbGpPWpGaD
Albendazole—Renal failure acute—Cisplatin—esophageal cancer	0.000152	0.0339	CcSEcCtD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000149	0.000587	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000148	0.000583	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000147	0.000578	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000146	0.000574	CbGpPWpGaD
Albendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	0.000144	0.000567	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CCND1—esophageal cancer	0.000143	0.000562	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000139	0.000548	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.000139	0.000547	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000139	0.000547	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CDKN1A—esophageal cancer	0.000138	0.000544	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000132	0.00052	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000132	0.000519	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—EP300—esophageal cancer	0.000131	0.000517	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000131	0.000517	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	0.00013	0.000513	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—RB1—esophageal cancer	0.00013	0.000511	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.000129	0.000508	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—MYC—esophageal cancer	0.000128	0.000504	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000127	0.000501	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000126	0.000497	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000126	0.000496	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000125	0.000492	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000125	0.00049	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000124	0.000486	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000122	0.000482	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.000121	0.000477	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000121	0.000476	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000121	0.000476	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000121	0.000476	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00012	0.000471	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000118	0.000466	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000118	0.000466	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000117	0.000461	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—RB1—esophageal cancer	0.000116	0.000457	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000116	0.000456	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000115	0.000453	CbGpPWpGaD
Albendazole—Pancytopenia—Cisplatin—esophageal cancer	0.000115	0.0257	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle—MYC—esophageal cancer	0.000115	0.000451	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000114	0.000449	CbGpPWpGaD
Albendazole—Renal failure acute—Capecitabine—esophageal cancer	0.000112	0.025	CcSEcCtD
Albendazole—CYP1A1—PPARA activates gene expression—EP300—esophageal cancer	0.000109	0.000427	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—esophageal cancer	0.000107	0.000423	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000107	0.000421	CbGpPWpGaD
Albendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—esophageal cancer	0.000106	0.000418	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC52A3—esophageal cancer	0.000102	0.000402	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—BLVRB—esophageal cancer	0.000102	0.000402	CbGpPWpGaD
Albendazole—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000102	0.0228	CcSEcCtD
Albendazole—TUBB4B—Cell Cycle—CDKN2A—esophageal cancer	0.000102	0.000402	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	9.96e-05	0.000392	CbGpPWpGaD
Albendazole—Aplastic anaemia—Methotrexate—esophageal cancer	9.94e-05	0.0222	CcSEcCtD
Albendazole—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	9.83e-05	0.000386	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—esophageal cancer	9.65e-05	0.000379	CbGpPWpGaD
Albendazole—Urinary tract disorder—Cisplatin—esophageal cancer	9.57e-05	0.0214	CcSEcCtD
Albendazole—Liver function test abnormal—Capecitabine—esophageal cancer	9.53e-05	0.0213	CcSEcCtD
Albendazole—Urethral disorder—Cisplatin—esophageal cancer	9.5e-05	0.0212	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle—TP53—esophageal cancer	9.41e-05	0.00037	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	9.37e-05	0.000368	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	9.33e-05	0.000367	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	9.24e-05	0.000363	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	9.16e-05	0.00036	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	9.14e-05	0.00036	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—EP300—esophageal cancer	8.88e-05	0.000349	CbGpPWpGaD
Albendazole—Immune system disorder—Cisplatin—esophageal cancer	8.75e-05	0.0195	CcSEcCtD
Albendazole—CYP1A1—Metabolism—CA1—esophageal cancer	8.7e-05	0.000342	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC10A2—esophageal cancer	8.7e-05	0.000342	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CCND1—esophageal cancer	8.63e-05	0.000339	CbGpPWpGaD
Albendazole—Alopecia—Cisplatin—esophageal cancer	8.56e-05	0.0191	CcSEcCtD
Albendazole—Pancytopenia—Capecitabine—esophageal cancer	8.48e-05	0.0189	CcSEcCtD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	8.41e-05	0.000331	CbGpPWpGaD
Albendazole—Neutropenia—Capecitabine—esophageal cancer	8.35e-05	0.0186	CcSEcCtD
Albendazole—TUBB4B—Cell Cycle—CDKN1A—esophageal cancer	8.34e-05	0.000328	CbGpPWpGaD
Albendazole—Renal failure acute—Methotrexate—esophageal cancer	8.33e-05	0.0186	CcSEcCtD
Albendazole—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.31e-05	0.000327	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	8.22e-05	0.000323	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	8.18e-05	0.000322	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—BLVRB—esophageal cancer	8.17e-05	0.000321	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC52A3—esophageal cancer	8.17e-05	0.000321	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CA2—esophageal cancer	7.95e-05	0.000313	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—EP300—esophageal cancer	7.94e-05	0.000312	CbGpPWpGaD
Albendazole—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	7.89e-05	0.0176	CcSEcCtD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	7.77e-05	0.000306	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MYC—esophageal cancer	7.74e-05	0.000304	CbGpPWpGaD
Albendazole—Leukopenia—Cisplatin—esophageal cancer	7.55e-05	0.0169	CcSEcCtD
Albendazole—Hepatobiliary disease—Capecitabine—esophageal cancer	7.53e-05	0.0168	CcSEcCtD
Albendazole—Agranulocytosis—Capecitabine—esophageal cancer	7.43e-05	0.0166	CcSEcCtD
Albendazole—CYP1A1—Metabolism—PLCE1—esophageal cancer	7.39e-05	0.000291	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ADH7—esophageal cancer	7.39e-05	0.000291	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.34e-05	0.000289	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	7.32e-05	0.000288	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	7.31e-05	0.000288	CbGpPWpGaD
Albendazole—Hepatitis—Capecitabine—esophageal cancer	7.14e-05	0.0159	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	7.13e-05	0.0159	CcSEcCtD
Albendazole—Liver function test abnormal—Methotrexate—esophageal cancer	7.1e-05	0.0158	CcSEcCtD
Albendazole—Urinary tract disorder—Capecitabine—esophageal cancer	7.05e-05	0.0157	CcSEcCtD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	7.05e-05	0.000277	CbGpPWpGaD
Albendazole—Urethral disorder—Capecitabine—esophageal cancer	7e-05	0.0156	CcSEcCtD
Albendazole—ABCB1—Metabolism—CA1—esophageal cancer	6.95e-05	0.000273	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC10A2—esophageal cancer	6.95e-05	0.000273	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MYC—esophageal cancer	6.92e-05	0.000272	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	6.85e-05	0.00027	CbGpPWpGaD
Albendazole—Erythema multiforme—Capecitabine—esophageal cancer	6.75e-05	0.0151	CcSEcCtD
Albendazole—Thrombocytopenia—Cisplatin—esophageal cancer	6.74e-05	0.015	CcSEcCtD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	6.7e-05	0.000264	CbGpPWpGaD
Albendazole—Skin disorder—Cisplatin—esophageal cancer	6.69e-05	0.0149	CcSEcCtD
Albendazole—CYP1A2—Metabolism—SLC52A3—esophageal cancer	6.52e-05	0.000257	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—BLVRB—esophageal cancer	6.52e-05	0.000257	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ADH1B—esophageal cancer	6.48e-05	0.000255	CbGpPWpGaD
Albendazole—Immune system disorder—Capecitabine—esophageal cancer	6.45e-05	0.0144	CcSEcCtD
Albendazole—ABCB1—Metabolism—CA2—esophageal cancer	6.35e-05	0.00025	CbGpPWpGaD
Albendazole—Alopecia—Capecitabine—esophageal cancer	6.31e-05	0.0141	CcSEcCtD
Albendazole—Pancytopenia—Methotrexate—esophageal cancer	6.31e-05	0.0141	CcSEcCtD
Albendazole—Neutropenia—Methotrexate—esophageal cancer	6.21e-05	0.0139	CcSEcCtD
Albendazole—CYP1A1—Metabolism—TYMP—esophageal cancer	6.2e-05	0.000244	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	6.06e-05	0.000238	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP26A1—esophageal cancer	6.03e-05	0.000237	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ADH7—esophageal cancer	5.91e-05	0.000232	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PLCE1—esophageal cancer	5.91e-05	0.000232	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALOX15—esophageal cancer	5.87e-05	0.000231	CbGpPWpGaD
Albendazole—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	5.87e-05	0.0131	CcSEcCtD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.86e-05	0.00023	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.83e-05	0.000229	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—esophageal cancer	5.68e-05	0.000223	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTO1—esophageal cancer	5.6e-05	0.00022	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TPI1—esophageal cancer	5.6e-05	0.00022	CbGpPWpGaD
Albendazole—Hepatobiliary disease—Methotrexate—esophageal cancer	5.6e-05	0.0125	CcSEcCtD
Albendazole—Vertigo—Capecitabine—esophageal cancer	5.59e-05	0.0125	CcSEcCtD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.57e-05	0.000219	CbGpPWpGaD
Albendazole—Leukopenia—Capecitabine—esophageal cancer	5.57e-05	0.0124	CcSEcCtD
Albendazole—CYP1A2—Metabolism—CA1—esophageal cancer	5.55e-05	0.000218	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC10A2—esophageal cancer	5.55e-05	0.000218	CbGpPWpGaD
Albendazole—Agranulocytosis—Methotrexate—esophageal cancer	5.53e-05	0.0123	CcSEcCtD
Albendazole—Body temperature increased—Cisplatin—esophageal cancer	5.44e-05	0.0121	CcSEcCtD
Albendazole—CYP1A1—Metabolism—ALDOB—esophageal cancer	5.37e-05	0.000211	CbGpPWpGaD
Albendazole—Hepatitis—Methotrexate—esophageal cancer	5.32e-05	0.0119	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	5.26e-05	0.0117	CcSEcCtD
Albendazole—Urinary tract disorder—Methotrexate—esophageal cancer	5.25e-05	0.0117	CcSEcCtD
Albendazole—Urethral disorder—Methotrexate—esophageal cancer	5.21e-05	0.0116	CcSEcCtD
Albendazole—ABCB1—Metabolism—ADH1B—esophageal cancer	5.18e-05	0.000204	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GAPDH—esophageal cancer	5.17e-05	0.000203	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CRABP1—esophageal cancer	5.13e-05	0.000202	CbGpPWpGaD
Albendazole—Hypersensitivity—Cisplatin—esophageal cancer	5.07e-05	0.0113	CcSEcCtD
Albendazole—CYP1A2—Metabolism—CA2—esophageal cancer	5.07e-05	0.000199	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.07e-05	0.000199	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC52A3—esophageal cancer	5.03e-05	0.000198	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—BLVRB—esophageal cancer	5.03e-05	0.000198	CbGpPWpGaD
Albendazole—Erythema multiforme—Methotrexate—esophageal cancer	5.03e-05	0.0112	CcSEcCtD
Albendazole—Thrombocytopenia—Capecitabine—esophageal cancer	4.97e-05	0.0111	CcSEcCtD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.96e-05	0.000195	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TYMP—esophageal cancer	4.95e-05	0.000195	CbGpPWpGaD
Albendazole—Skin disorder—Capecitabine—esophageal cancer	4.93e-05	0.011	CcSEcCtD
Albendazole—CYP1A1—Metabolism—GNG7—esophageal cancer	4.88e-05	0.000192	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.86e-05	0.000191	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP26A1—esophageal cancer	4.81e-05	0.000189	CbGpPWpGaD
Albendazole—Immune system disorder—Methotrexate—esophageal cancer	4.8e-05	0.0107	CcSEcCtD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.75e-05	0.000187	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ADH7—esophageal cancer	4.71e-05	0.000185	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLCE1—esophageal cancer	4.71e-05	0.000185	CbGpPWpGaD
Albendazole—Alopecia—Methotrexate—esophageal cancer	4.7e-05	0.0105	CcSEcCtD
Albendazole—ABCB1—Metabolism—ALOX15—esophageal cancer	4.69e-05	0.000185	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.66e-05	0.000183	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALDH2—esophageal cancer	4.57e-05	0.00018	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TPI1—esophageal cancer	4.48e-05	0.000176	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTO1—esophageal cancer	4.48e-05	0.000176	CbGpPWpGaD
Albendazole—Vomiting—Cisplatin—esophageal cancer	4.38e-05	0.00977	CcSEcCtD
Albendazole—CYP1A1—Metabolism—GSTT1—esophageal cancer	4.35e-05	0.000171	CbGpPWpGaD
Albendazole—Rash—Cisplatin—esophageal cancer	4.34e-05	0.00969	CcSEcCtD
Albendazole—Dermatitis—Cisplatin—esophageal cancer	4.34e-05	0.00968	CcSEcCtD
Albendazole—CYP1A1—Metabolism—CYP2A6—esophageal cancer	4.3e-05	0.000169	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALDOB—esophageal cancer	4.29e-05	0.000169	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC10A2—esophageal cancer	4.28e-05	0.000168	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA1—esophageal cancer	4.28e-05	0.000168	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.28e-05	0.000168	CbGpPWpGaD
Albendazole—Vertigo—Methotrexate—esophageal cancer	4.16e-05	0.00928	CcSEcCtD
Albendazole—Gastrointestinal pain—Capecitabine—esophageal cancer	4.15e-05	0.00926	CcSEcCtD
Albendazole—Leukopenia—Methotrexate—esophageal cancer	4.14e-05	0.00925	CcSEcCtD
Albendazole—CYP1A2—Metabolism—ADH1B—esophageal cancer	4.13e-05	0.000163	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GAPDH—esophageal cancer	4.13e-05	0.000162	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.12e-05	0.000162	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CRABP1—esophageal cancer	4.09e-05	0.000161	CbGpPWpGaD
Albendazole—Nausea—Cisplatin—esophageal cancer	4.09e-05	0.00913	CcSEcCtD
Albendazole—CYP1A1—Metabolism—ENO1—esophageal cancer	4.07e-05	0.00016	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS1—esophageal cancer	4.07e-05	0.00016	CbGpPWpGaD
Albendazole—Urticaria—Capecitabine—esophageal cancer	4.03e-05	0.009	CcSEcCtD
Albendazole—CYP1A1—Metabolism—PSME1—esophageal cancer	4.01e-05	0.000158	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PSME2—esophageal cancer	4.01e-05	0.000158	CbGpPWpGaD
Albendazole—Body temperature increased—Capecitabine—esophageal cancer	4.01e-05	0.00895	CcSEcCtD
Albendazole—Abdominal pain—Capecitabine—esophageal cancer	4.01e-05	0.00895	CcSEcCtD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.99e-05	0.000157	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TYMP—esophageal cancer	3.95e-05	0.000155	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA2—esophageal cancer	3.91e-05	0.000154	CbGpPWpGaD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	3.91e-05	0.00874	CcSEcCtD
Albendazole—ABCB1—Metabolism—GNG7—esophageal cancer	3.89e-05	0.000153	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP26A1—esophageal cancer	3.84e-05	0.000151	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALOX15—esophageal cancer	3.75e-05	0.000147	CbGpPWpGaD
Albendazole—Hypersensitivity—Capecitabine—esophageal cancer	3.74e-05	0.00835	CcSEcCtD
Albendazole—Thrombocytopenia—Methotrexate—esophageal cancer	3.7e-05	0.00826	CcSEcCtD
Albendazole—Skin disorder—Methotrexate—esophageal cancer	3.67e-05	0.00819	CcSEcCtD
Albendazole—ABCB1—Metabolism—ALDH2—esophageal cancer	3.65e-05	0.000144	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ADH7—esophageal cancer	3.64e-05	0.000143	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.64e-05	0.000143	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TPI1—esophageal cancer	3.57e-05	0.000141	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTO1—esophageal cancer	3.57e-05	0.000141	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.5e-05	0.000138	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTT1—esophageal cancer	3.47e-05	0.000137	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP1B1—esophageal cancer	3.46e-05	0.000136	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.43e-05	0.000135	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALDOB—esophageal cancer	3.43e-05	0.000135	CbGpPWpGaD
Albendazole—Dizziness—Capecitabine—esophageal cancer	3.36e-05	0.00749	CcSEcCtD
Albendazole—CYP1A2—Metabolism—GAPDH—esophageal cancer	3.3e-05	0.00013	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CRABP1—esophageal cancer	3.27e-05	0.000129	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP19A1—esophageal cancer	3.26e-05	0.000128	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ENO1—esophageal cancer	3.25e-05	0.000128	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS1—esophageal cancer	3.25e-05	0.000128	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.25e-05	0.000128	CbGpPWpGaD
Albendazole—Vomiting—Capecitabine—esophageal cancer	3.23e-05	0.0072	CcSEcCtD
Albendazole—ABCB1—Metabolism—PSME1—esophageal cancer	3.2e-05	0.000126	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PSME2—esophageal cancer	3.2e-05	0.000126	CbGpPWpGaD
Albendazole—Rash—Capecitabine—esophageal cancer	3.2e-05	0.00714	CcSEcCtD
Albendazole—Dermatitis—Capecitabine—esophageal cancer	3.2e-05	0.00714	CcSEcCtD
Albendazole—CYP3A4—Metabolism—ADH1B—esophageal cancer	3.19e-05	0.000126	CbGpPWpGaD
Albendazole—Headache—Capecitabine—esophageal cancer	3.18e-05	0.0071	CcSEcCtD
Albendazole—CYP1A2—Metabolism—GNG7—esophageal cancer	3.11e-05	0.000122	CbGpPWpGaD
Albendazole—Gastrointestinal pain—Methotrexate—esophageal cancer	3.09e-05	0.0069	CcSEcCtD
Albendazole—CYP3A4—Metabolism—TYMP—esophageal cancer	3.05e-05	0.00012	CbGpPWpGaD
Albendazole—Nausea—Capecitabine—esophageal cancer	3.01e-05	0.00673	CcSEcCtD
Albendazole—Urticaria—Methotrexate—esophageal cancer	3e-05	0.0067	CcSEcCtD
Albendazole—Abdominal pain—Methotrexate—esophageal cancer	2.99e-05	0.00667	CcSEcCtD
Albendazole—Body temperature increased—Methotrexate—esophageal cancer	2.99e-05	0.00667	CcSEcCtD
Albendazole—CYP1A1—Metabolism—HMOX1—esophageal cancer	2.97e-05	0.000117	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.97e-05	0.000117	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.91e-05	0.000115	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALDH2—esophageal cancer	2.91e-05	0.000115	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.89e-05	0.000114	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCB1—esophageal cancer	2.85e-05	0.000112	CbGpPWpGaD
Albendazole—Hypersensitivity—Methotrexate—esophageal cancer	2.78e-05	0.00621	CcSEcCtD
Albendazole—CYP1A2—Metabolism—GSTT1—esophageal cancer	2.77e-05	0.000109	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.77e-05	0.000109	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TPI1—esophageal cancer	2.76e-05	0.000108	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.76e-05	0.000108	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2A6—esophageal cancer	2.74e-05	0.000108	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.73e-05	0.000107	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.64e-05	0.000104	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.6e-05	0.000102	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS1—esophageal cancer	2.6e-05	0.000102	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ENO1—esophageal cancer	2.6e-05	0.000102	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PSME2—esophageal cancer	2.56e-05	0.000101	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PSME1—esophageal cancer	2.56e-05	0.000101	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.55e-05	0.0001	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.52e-05	9.92e-05	CbGpPWpGaD
Albendazole—Dizziness—Methotrexate—esophageal cancer	2.5e-05	0.00558	CcSEcCtD
Albendazole—Vomiting—Methotrexate—esophageal cancer	2.4e-05	0.00536	CcSEcCtD
Albendazole—CYP3A4—Metabolism—GNG7—esophageal cancer	2.4e-05	9.44e-05	CbGpPWpGaD
Albendazole—Rash—Methotrexate—esophageal cancer	2.38e-05	0.00532	CcSEcCtD
Albendazole—Dermatitis—Methotrexate—esophageal cancer	2.38e-05	0.00531	CcSEcCtD
Albendazole—ABCB1—Metabolism—HMOX1—esophageal cancer	2.37e-05	9.33e-05	CbGpPWpGaD
Albendazole—Headache—Methotrexate—esophageal cancer	2.37e-05	0.00528	CcSEcCtD
Albendazole—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.25e-05	8.84e-05	CbGpPWpGaD
Albendazole—Nausea—Methotrexate—esophageal cancer	2.24e-05	0.00501	CcSEcCtD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.23e-05	8.79e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP1B1—esophageal cancer	2.21e-05	8.68e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.16e-05	8.48e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.14e-05	8.41e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.11e-05	8.31e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.08e-05	8.16e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS1—esophageal cancer	2e-05	7.88e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ENO1—esophageal cancer	2e-05	7.88e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PSME2—esophageal cancer	1.97e-05	7.77e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PSME1—esophageal cancer	1.97e-05	7.77e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CREBBP—esophageal cancer	1.91e-05	7.5e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.89e-05	7.45e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.86e-05	7.31e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.82e-05	7.15e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NOS3—esophageal cancer	1.71e-05	6.71e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.7e-05	6.7e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.6e-05	6.3e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—esophageal cancer	1.56e-05	6.14e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CREBBP—esophageal cancer	1.52e-05	5.99e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.46e-05	5.75e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.4e-05	5.52e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.37e-05	5.41e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NOS3—esophageal cancer	1.36e-05	5.36e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—EP300—esophageal cancer	1.3e-05	5.1e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—esophageal cancer	1.25e-05	4.9e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.21e-05	4.78e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NOS3—esophageal cancer	1.09e-05	4.28e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—EP300—esophageal cancer	1.04e-05	4.08e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—esophageal cancer	9.95e-06	3.91e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CA—esophageal cancer	9.6e-06	3.78e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CREBBP—esophageal cancer	9.38e-06	3.69e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NOS3—esophageal cancer	8.4e-06	3.3e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—EP300—esophageal cancer	8.27e-06	3.25e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—esophageal cancer	7.68e-06	3.02e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CA—esophageal cancer	7.67e-06	3.02e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—EP300—esophageal cancer	6.39e-06	2.51e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CA—esophageal cancer	6.12e-06	2.41e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.72e-06	1.86e-05	CbGpPWpGaD
